Results 31 to 40 of about 6,395,772 (154)

Scoping review protocol on nonpharmacological interventions for possible sarcopenia or sarcopenia in community-dwelling older adults [PDF]

, 2022
Abstract Background: Preventing sarcopenia earlier in community has become a new recommendation in recent years. Several nonpharmacological interventions to reduce the risk of sarcopenia in community-dwelling older people have been proposed, therefore there is a need to identify which of these interventions are effective.
Ya Shi, Emma Stanmore, Chris Todd
openaire   +1 more source

Circulatory titin and miR-451a are possible sarcopenia biomarkers in elderly people. [PDF]

Front Aging
IntroductionSarcopenia is a clinical syndrome characterized by decline of muscle mass, strength or physical performance that occur with advancing age. Diagnosis is currently based on assessment of muscle mass and performance. New biomarkers are needed in clinical practice for diagnosis, monitoring and treatment of sarcopenia.
Mancuso R, Citterio LA, Agostini S, Miglioli R, Nuzzi R, Antolini L, Trecate F, Clerici M.   +7 more
europepmc   +6 more sources

Sarcopenia and mortality in different clinical conditions: A meta-analysis [PDF]

, 2021
Objectives: Sarcopenia is recognized to be a health problem which is as serious as obesity, but its relevance to mortality is unclear. We conducted a meta-analysis of cohort studies on lean mass and mortality in populations with different health ...
Yip, BHK, Cheung, CL, Chan, M, Cheng, KKY, Au, PCM, Li, GHY, Cheung, C-L, Cheung, BMY, Wu, C-H, Wu, CH, Lee, VHF, Li, H-L, Lee, GKY, Li, HL, Wong, ICK, Mok, J, Au, CM, Grace Koon-Yee Lee, Ian Chi-Kei Wong, Philip Chun-Ming Au, Benjamin Hon-Kei Yip, Cheng, KYK, Marcus Chan, Hang-Long Li, Bernard Man-Yung Cheung, Li, HY, James Mok, Ching-Lung Cheung, Kenneth King-Yip Cheng, Lee, KYG, Yip, HKB, Gloria Hoi-Yee Li, Chih-Hsing Wu, Victor Ho-Fun Lee   +33 more
core   +1 more source

Association of Nutritional Status and Possible Sarcopenia Among Formerly Older Homeless Adults in Supportive Housing, Thailand. [PDF]

Nutrients
Background/Objectives: Possible sarcopenia and malnutrition are critical public health concerns among older adults, particularly in vulnerable populations such as those with a history of homelessness.
Whaikid P, Piaseu N.
europepmc   +2 more sources

Prevalence of sarcopenia and sarcopenic obesity in Korean adults: The Korean Sarcopenic Obesity Study (KSOS) [PDF]

, 2009
*Context:* Sarcopenic obesity (SO), a combination of excess weight and reduced muscle mass and/or strength, is suggested to be associated with an increased risk of adverse health outcomes.
Tae Nyun Kim, Sei Hyun Baik, Hyun Joo Kang, Sae Jeong Yang, Wook Song, Ji A Seo, Sin Gon Kim, Hye Jin Yoo, Nan Hee Kim, Kang Il Lim, Kyung Mook Choi, Dong Seop Choi   +11 more
core  

Health outcomes of sarcopenia: a consensus report by the outcome working group of the Global Leadership Initiative in Sarcopenia (GLIS) [PDF]

The Global Leadership Initiative in Sarcopenia (GLIS) aims to standardize the definition and diagnostic criteria for sarcopenia into one unifying, common classification.
Woo, Jean, Lim, Wee Shiong, Beaudart, Charlotte, Yamada, Yosuke, The Global Leadership Initiative in Sarcopenia (GLIS) group, Duque, Gustavo, von Haehling, Stephan, Sanchez-Rodriguez, Dolores, Alcazar, Julian, Reginster, Jean Yves, Aprahamian, Ivan, Batsis, John A., Reginster, Jean-Yves, Prado, Carla M., Sim, Marc, Global Leadership Initiative in Sarcopenia (GLIS) group, Batsis, John A, Haehling, Stephan von, Prado, Carla M   +18 more
core   +2 more sources

Possibility of small-molecule-based pharmacotherapy for sarcopenia

The Journal of Physical Fitness and Sports Medicine, 2015
Muscle mass and strength decline with age. When severe, the loss is called sarcopenia. Sarcopenia is drawing attention worldwide, especially in highly aged societies, as a disease that should be treated. At present, we have limited tools to combat sarcopenia (e.g.
Watanabe, Yuka, Miyagoe-Suzuki, Yuko
openaire   +3 more sources

Biomarkers of sarcopenia in clinical trials-recommendations from the International Working Group on Sarcopenia.

, 2012
Sarcopenia, the age-related skeletal muscle decline, is associated with relevant clinical and socioeconomic negative outcomes in older persons. The study of this phenomenon and the development of preventive/therapeutic strategies represent public health ...
VAN KAN G.A., AUBERTIN LEHEUDRE M., SIEBER C.C., ROUBENOFF R., VRIJBLOED J.W., INTERNATIONAL WORKING GROUP ON SARCOPENIA, ANKER S.D., PAHOR M., ZAMBONI, Mauro, FIELDING R.A., CEDARBAUM J.M., GOODPASTER B., EVANS W.J., ISAAC M., LAURENT D., CESARI M., MORLEY J.E., ROLLAND Y., VELLAS B., HELLERSTEIN M., RUTKOVER S.D., M'RINI C.   +21 more
core   +1 more source

Diagnostic performance of calf circumference, SARC-F, and SARC-CalF for possible sarcopenia screening in Indonesia [PDF]

, 2023
Asian working group for sarcopenia (AWGS) recently introduced “possible sarcopenia” diagnosis for early identification of sarcopenia in the primary healthcare. For initial screening, 3 modalities, i.e.
Hadiq Firdausi, Stefanus G. Kandinata, Ichwani, Jusri, Jusri Ichwani, Novira Widajanti, Firas F. Alkaff, Kandinata, Stefanus G., Widajanti, Novira, Firdausi, Hadiq, Alkaff, Firas F.; id_orcid, I. G. P. S. Aryana, Aryana, I. G.P.S.   +11 more
core   +1 more source

SARC-F as a Screening Tool for Sarcopenia and Possible Sarcopenia Proposed by AWGS 2019 in Hospitalized Older Adults

The Journal of nutrition, health and aging, 2020
The SARC-F questionnaire is a sarcopenia screening tool. However, the validity of the SARC-F score ≥4 (SARC-F≥4) for the evaluation of sarcopenia in the hospital setting has not been investigated. This study investigated the validity of SARC-F≥4 as a screening tool for sarcopenia among hospitalized older adults.Cross-sectional retrospective study.A ...
Ishida, Y., Maeda, Keisuke, Nonogaki, T., Shimizu, A., Yamanaka, Y., Matsuyama, R., Kato, R., Ueshima, J., Murotani, K., Mori, N.   +9 more
openaire   +3 more sources